Omvoh (mirikizumab-mrkz) Coverage Criteria
Customize your policy alerts
Sign up for Colorado Rocky Mountain Health Plans Policy CS2026D00129K alerts
Get alerted when Policy CS2026D00129K changes without checking for updates manually.
Monitor payer policy activity
Medical benefit prior authorization and medical-necessity coverage for Omvoh in adults with moderately to severely active ulcerative colitis or Crohn's disease; self-administered subcutaneous Omvoh is covered under the pharmacy benefit.
The policy history states that language was added clarifying that this Medical Benefit Drug Policy does not apply to Florida.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.